110 related articles for article (PubMed ID: 11776563)
21. Effects of danazol on coagulant activity in the rat.
Lox CD; Heine MW; DeLeon F; Prein S
Int J Fertil; 1992; 37(1):48-52. PubMed ID: 1348736
[TBL] [Abstract][Full Text] [Related]
22. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
23. [Alterations in coagulation in patients during transplant conditioning regimen before allogeneic hematopoietic stem cell transplantation].
Jiang Q; Huang XJ; Liu KY; Chen H; Chen YH; Gao ZY; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):173-7. PubMed ID: 16792919
[TBL] [Abstract][Full Text] [Related]
24. Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up.
Chaloupecký V; Svobodová I; Hadacová I; Tomek V; Hucín B; Tláskal T; Janousek J; Reich O; Skovránek J
Heart; 2005 Jan; 91(1):73-9. PubMed ID: 15604339
[TBL] [Abstract][Full Text] [Related]
25. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
27. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the coagulation system in children with two-ventricle congenital heart disease.
Odegard KC; Zurakowski D; Hornykewycz S; DiNardo JA; Castro RA; Neufeld EJ; Laussen PC
Ann Thorac Surg; 2007 May; 83(5):1797-803. PubMed ID: 17462402
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics of tuberculosis in patients with liver cirrhosis.
Cho YJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Respirology; 2007 May; 12(3):401-5. PubMed ID: 17539845
[TBL] [Abstract][Full Text] [Related]
30. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
31. [Fatal anaphylactic shock caused by rifampicin in a patient with HIV infection].
Inmaculada Rubio M; Alvarez del Vayo C; Cisneros JM; Viciana P; Martínez-Marcos F
Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):200-1. PubMed ID: 8695696
[No Abstract] [Full Text] [Related]
32. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
[TBL] [Abstract][Full Text] [Related]
33. Analysis of coagulation parameters in the early period after kidney transplantation.
Pawlicki J; Cierpka L; Król R; Ziaja J
Transplant Proc; 2007 Nov; 39(9):2754-5. PubMed ID: 18021978
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
36. Coagulation and fibrinolysis are in balance after moderate exercise in middle-aged participants.
Menzel K; Hilberg T
Clin Appl Thromb Hemost; 2009; 15(3):348-55. PubMed ID: 19022797
[TBL] [Abstract][Full Text] [Related]
37. [[LIVER TOXICITY DUE TO RIFAMPICIN MONOTHERAPY IN LATENT TUBERCULOSIS INFECTION].].
Ito K
Kekkaku; 2016 May; 91(5):509-513. PubMed ID: 28661592
[TBL] [Abstract][Full Text] [Related]
38. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
39. Tigecycline treatment causes a decrease in fibrinogen levels.
Zhang Q; Zhou S; Zhou J
Antimicrob Agents Chemother; 2015 Mar; 59(3):1650-5. PubMed ID: 25547356
[TBL] [Abstract][Full Text] [Related]
40. Connection between genetically determined blood coagulation factors and haemorheology.
Pongrácz E; Andrikovics H; Bernát IS; Nagy Z
Clin Hemorheol Microcirc; 2008; 39(1-4):333-41. PubMed ID: 18503143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
